PERSONAL FINANCEWhat Is Gross Income? Definition and How to CalculateBy Alexander NicollJul 24, 2019 9:47 AM EDT
MARKETSJob Cuts Hit Highest Mark for First Quarter in a DecadeBy Alexander NicollApr 4, 2019 12:40 PM EDT
STOCKSGalapagos Soars After Rheumatoid Arthritis Drug Meets Primary EndpointBy Alexander NicollMar 29, 2019 11:06 AM EDT
STOCKSTricida Surges on Positive Results of Chronic Kidney Disease TreatmentBy Alexander NicollMar 28, 2019 4:37 PM EDT
STOCKSConn's Fourth-Quarter Revenue Disappoints but Earnings BeatBy Alexander NicollMar 26, 2019 2:53 PM EDT
STOCKSCintas Drops After Missing Earnings, Revenue Estimates for QuarterBy Alexander NicollMar 22, 2019 2:23 PM EDT
STOCKSCanadian Solar Spirals Downward After Low 2019 GuidanceBy Alexander NicollMar 21, 2019 12:01 PM EDT
STOCKSCasey's General Store Earnings Show Steady Growth, EPS BeatsBy Alexander NicollMar 12, 2019 4:17 PM EDT
STOCKSInternational Game Technology Plummets as Adjusted Earnings Miss ForecastsBy Alexander NicollMar 7, 2019 12:06 PM EST
INVESTINGUniversal Healthcare Services Rises on Revenue, EPS BeatsBy Alexander NicollFeb 28, 2019 4:03 PM EST
STOCKSTransocean Falls Slightly After Losses Higher Than ExpectedBy Alexander NicollFeb 19, 2019 4:41 PM EST
INVESTINGInternational Flavors & Fragrances Plummets After Poor Fourth QuarterBy Alexander NicollFeb 14, 2019 1:10 PM EST
STOCKSWolverine World Wide Rises After Share Buyback AnnouncementBy Alexander NicollFeb 12, 2019 4:28 PM EST
STOCKSBrinker International Falls Despite Higher EPS and Net Income in Q2By Alexander NicollJan 29, 2019 4:20 PM EST
COMMODITIESNew EIA Report Predicts U.S. Energy Independent by 2020By Alexander NicollJan 24, 2019 10:51 PM EST
STOCKSZumiez Rises More Than 7% After Hiking Guidance, EPS ForecastBy Alexander NicollJan 10, 2019 4:32 PM EST
STOCKSGoogle Tags Los Angeles Mall as New Space for Office CampusBy Alexander NicollJan 8, 2019 4:16 PM EST
STOCKSWhy Investors Should Favor Smaller Biotech CompaniesBy Alexander NicollOct 24, 2018 11:04 PM EDT
RETIREMENT3 Important Things to Remember When Planning for RetirementBy Alexander NicollAug 4, 2018 7:19 AM EDT
STOCKSMerck Beats Estimates and Raises Guidance, But Stock Still FallsBy Alexander NicollJul 27, 2018 10:20 AM EDT
STOCKSBiogen Plummets as Alzheimer Drug Shows Little Efficacy in TrialBy Alexander NicollJul 26, 2018 3:43 PM EDT
STOCKSAllergan Announces $2 Billion Share Buyback Program, Raises GuidanceBy Alexander NicollJul 26, 2018 2:06 PM EDT
STOCKSBiogen Shares Plummet Despite Alzheimer's Drug Exceeding ExpectationsBy Alexander NicollJul 25, 2018 6:46 PM EDT
STOCKSBiogen's Big Alzheimer's Presentation on Wednesday: What You Need to KnowBy Alexander NicollJul 24, 2018 5:46 PM EDT
STOCKSBiogen Jumps on Earnings Beat Ahead of Alzheimer's PresentationBy Alexander NicollJul 24, 2018 12:22 PM EDT
VIDEOIntern Wrap-Up: Weighing in on Jim Cramer's AAP Conference CallBy Alexander NicollJul 23, 2018 9:28 AM EDT
PERSONAL FINANCEHow Millennials Can Retire in Their Early 60sBy Alexander NicollJul 23, 2018 7:30 AM EDT
STOCKSIntuitive Surgical Gets New Price Targets After Earnings BeatBy Alexander NicollJul 20, 2018 12:46 PM EDT
STOCKSPrepare for Volatility Around Biogen Ahead of Alzheimer's Presentation: LeerinkBy Alexander NicollJul 20, 2018 8:35 AM EDT
STOCKSIndivior soars on court ruling blocking sales of rival's generic opioid drugBy Alexander NicollJul 16, 2018 10:58 AM EDT
PERSONAL FINANCEHow to Prevent Debt From Destroying Your RetirementBy Alexander NicollJul 16, 2018 7:00 AM EDT
INVESTINGCDC Expands Warning on Kellogg's Honey Smacks CerealBy Alexander NicollJul 13, 2018 12:23 PM EDT
STOCKSOncoCyte surges on 'encouraging' results for diagnostic test for cancerBy Alexander NicollJul 10, 2018 9:34 AM EDT
INVESTINGInvestors Ditch Soybeans With Agricultural ETFs SelloffBy Alexander NicollJul 9, 2018 3:52 PM EDT
RETIREMENT3 Great Investment Alternatives to Stocks For RetireesBy Alexander NicollJul 9, 2018 1:02 PM EDT
STOCKSAxovant, Benetic jump on agreement to develop gene therapy for MDBy Alexander NicollJul 9, 2018 11:04 AM EDT
INVESTINGBiogen shares soar on positive Alzheimer's drug resultsBy Alexander NicollJul 6, 2018 4:27 PM EDT
ETFs3 Big-Name ETFs Being Hurt by U.S. Trade War With ChinaBy Alexander NicollJul 6, 2018 12:09 PM EDT
INVESTINGWeedStreet Wrap: U.K. Next in Line for Medical CannabisBy Alexander NicollJul 5, 2018 6:23 PM EDT
STOCKSCompanies Already Affected by Trump's Global Trade WarBy Alexander NicollJul 5, 2018 9:55 AM EDT
